Publications by Professor Kathleen Liddell
Full list of publications by Professor Kathleen Liddell.
- Kathleen Liddell, Marcelo Corrales Compagnucci, Timo Minssen, Mark Fenwick, Mateo Aboy, The Law and Ethics of Data Sharing in Health Sciences, Springer, 2024
- Kathleen Liddell, O Corrigan, J McMillan, M Richards, C Weijer, The Limits of Consent, Oxford University Press, 2009
- Kathleen Liddell, Simon Ravenscroft, Thomas C. Berg, Roman Cholij, Simon Ravenscroft, ‘Morality, Religion and Patents’, in Patents on Life: Religious, Moral and Social Justice Aspects of Biotechnology and Intellectual Property (2019), 2018
- Kathleen Liddell, J Liddicoat, M Jordan, ‘IP Policies for Large Bioresources: the fiction, fantasy and future of openness (2019)’, in Global Genes, Local Concerns: Legal, Ethical and Scientific Challenges in International Biobanking, Edward Elgar Publishing, 2018
- Kathleen Liddell, H Ullrich, RM Hilty, M Lamping, J Drexl, WR Cornish, ‘The Origins and Structure of the TRIPS Agreement’, in TRIPS plus 20: From Trade Rules to Market Principles, Springer, 2016
- Kathleen Liddell, ‘Immorality and Patents: the exclusion of patents contrary to ordre public and morality’, in New Frontiers in the Philosophy of Intellectual Property (eds A Lever), 2012
- Kathleen Liddell, T Pogge, M Rimmer, K Rubenstein, ‘The Health Impact Fund: A Critique’, in Incentives for Global Health, 2010
- Kathleen Liddell, N. J. Smelser, Paul B. Baltes, ‘Litigation: Effects on Medical Research’, in International Encyclopedia of the Social & Behavioural Sciences, Peter Lang, 2001
- Kathleen Liddell, Mateo Aboy, Christina Crespo, Matt Jordan, Stuart Hogarth, J Powell, ‘Mapping the Patent Landscape of Cancer Diagnostics’, Nature Biotechnology, forthcoming
- Kathleen Liddell, Erik Hahn, Mateo Aboy, I. Glenn Cohen, ‘Cross-border telemedicine -A reason to 'smile'? also comment on ECJ, judgment of 11 September 2025 -C-115/24 (UJ/Austrian Dental Association)’, University of Cambridge Faculty of Law Research Paper, Paper No. 22/2025
- Kathleen Liddell, I Weldon, K Outterson, ‘Policy Options for Antimicrobial Resistance: Exploring Lessons From Environmental Governance’, Milbank Quarterly, 2025
- Kathleen Liddell, Mateo Aboy, Aparajita Lath, ‘Inventorship in the age of AI: examining the USPTO Guidance on AI-assisted inventions’, Journal of Intellectual Property Law & Practice, Volume 20, Issue 7, July 2025
- Kathleen Liddell, Mateo Aboy, Aparajita Lath, Timo Minssen, ‘The sufficiency of disclosure of AI inventions’, Journal of Intellectual Property Law & Practice, Volume 19, Issue 11, November 2024
- Kathleen Liddell, J Liddicoat, A Hamidzadeh, M Aboy, ‘How many drugs are repositioned each year in Europe?’, The Journal of World Intellectual Property, 2024(1): 1
- Kathleen Liddell, M Aboy, W N Price, S Raker et al., ‘The sufficiency of disclosure of medical artificial intelligence patents’, Nature Biotechnology, 42, 839–845 (2024)
- Kathleen Liddell, Isaac Weldon, Susan Rogers Van Katwyk, Steven J. Hoffman, Timo Minssen, Kevin Outterson, Stephanie Palmer, A. M. Viens, J Viñuales, ‘Analyzing antimicrobial resistance as a series of collective action problems’, Policy Studies Journal, 2024
- Kathleen Liddell, J Liddicoat, A Hamidzadeh, M Aboy, M Schito, T Minssen, D Simon, ‘New government drug repurposing programs: Opportunities and uncertainties’, Science Translational Medicine, 2024; 16(753): eadl0998
- Kathleen Liddell, Annie Mackley, Jeffrey M Skopek, Isabelle Le Gallez, Zoë Fritz, ‘The frontiers of medical negligence and diagnosis: an interview-based analysis’, Medical Law Review, Volume 31, Issue 4, Pages 485–500, 2023
- Kathleen Liddell, Isaac Weldon, Kathy Liddell, Susan Rogers Van Katwyk, Steven J Hoffman, Timo Minssen, Kevin Outterson, Stephanie Palmer, A M Viens, Jorge Viñuales, ‘A Pandemic Instrument Can Start Turning Collective Problems into Collective Solutions by Governing the Common-Pool Resource of Antimicrobial Effectiveness’, The Journal of Law, Medicine & Ethics, 50(S2): 17–25, 2023
- Kathleen Liddell, A Hamidzadeh, John Liddicoat, ‘Should Europe Adopt a Policy Like the US MODERN Labeling Act?’, European Health & Pharmaceutical Law Review, Volume 7, Pages 36–38, 2023
- Kathleen Liddell, Amy L Foreman, Sarah Franklin, Emily Jackson, Christina Rozeik, Kathy K Niakan, ‘Human embryo models: the importance of national policy and governance review’, Current Opinion in Genetics & Development, Volume 82, 102103, 2023
- Kathleen Liddell, J van der Scheer, A Ansari, M McLaughlin et al., ‘Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework’, BMC Public Health, 22, 1747 (2022)
- Kathleen Liddell, M Aboy, M Jordan, C Crespo, J Liddicoat, ‘European patent protection for medical uses of known products and drug repurposing’, Nature Biotechnology, 40(4), 2022
- Kathleen Liddell, David A Simon, Anneke Lucassen, ‘Patient data ownership: who owns your health?’, Journal of Law and the Biosciences, Volume 8, Issue 2, July–December 2021, lsab023
- Kathleen Liddell, I Le Gallez, J Skopek, I Kuhn, A Sagar, Z Fritz, ‘Montgomery's legal and practical impact: A systematic review at 6 years’, Journal of Evaluation in Clinical Practice, 2022; 28(4): 690–702, 2021
- Kathleen Liddell, Matthew Jordan, Johnathon Liddicoat, ‘An empirical study of large, human biobanks: intellectual property policies and financial conditions for access’, Journal of Law and the Biosciences, Volume 8, Issue 1, 2021
- Kathleen Liddell, Johnathon Liddicoat, Mateo Aboy et al., ‘Has the EU Incentive for Drug Repositioning Been Effective? An Empirical Analysis of the “+1” Regulatory Exclusivity’, IIC, Volume 52, Pages 825–851 (2021)
- Kathleen Liddell, Laura Bradford, Mateo Aboy, ‘Standard contractual clauses for cross-border transfers of health data after Schrems II’, Journal of Law and the Biosciences, Volume 8, Issue 1, January–June 2021, lsab007
- Kathleen Liddell, Cox C, Ansari A, McLaughlin M et al., ‘Developing an ethical framework for asymptomatic COVID-19 testing programmes in higher education institutions’, Wellcome Open Research, 6:101, 2021
- Kathleen Liddell, Z Fritz, J Huppert, R Holton, J Fuld, ‘Ethical principles and a practical approach to support policy making through the next phases of the COVID-19 pandemic and beyond’, Clinical Medicine, 2021; 21(2): e122–e125
- Kathleen Liddell, A Ruck Keene, A Holland, J Huppert, B Underwood, O Clark, S Barclay, ‘Isolating residents including wandering residents in care and group homes: Medical ethics and English law in the context of Covid-19’, (2020) International Journal of Law and Psychiatry (1 Dec)
- Kathleen Liddell, T Minssen, K Outterson, S Rogers Van Katwyk, P Batista, C Chandler, F Ciabuschi, S Harbarth, A Kesselheim, R Laxminarayan, M Osterholm, L Price, S Hoffman, ‘Social, cultural and economic aspects of antimicrobial resistance’, (2020) 98 Bulletin of the World Health Organisation 823-823A
- Kathleen Liddell, Laura Bradford, Mateo Aboy, ‘International Transfers of Health Data between the EU and US: A better approach for the US to ensure an ‘adequate’ level of protection’, (2020) 7(1) Journal of Law and the Biosciences lsaa055
- Kathleen Liddell, Laura Bradford, Mateo Aboy, ‘COVID-19 contact tracing apps: a stress test for privacy, the GDPR, and data protection regimes’, (2020) 7(1) Journal of Law and the Biosciences lsaa034
- Kathleen Liddell, J Skopek, S Palmer, S Martin, J Anderson, A Sagar, ‘Who gets the ventilator? Important legal rights in a pandemic’, (2020) 46 Journal of Medical Ethics 421
- Kathleen Liddell, S Martin, S Palmer, ‘Allocating Medical Resources in the Time of Covid-19 – Letter to the Editor’, (2020) The New England Journal of Medicine 382
- Kathleen Liddell, Mateo Aboy, Cristina Crespo, Neil Davey, John Liddicoat, Timo Minssen, M Aboy, C Crespo, N Davey, J Liddicoat, T Minssen, ‘One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-rejections?’, (2020) 38(3) Nature Biotechnology 279
- Kathleen Liddell, J Skopek, S Palmer, S Martin, J Anderson, A Sagar, ‘Deciding who gets the ventilator: Will some lives be lost unlawfully?’, (2020) Journal of Medical Ethics Blog
- Kathleen Liddell, Johnathon Liddicoat, Mateo Aboy, J Liddicoat, M Aboy, ‘The Effects of Myriad and Mayo on molecular test development in Europe and the US: Interviews from the Frontline’, (2020) 22 Vanderbilt Journal of Entertainment and Technology Law 785, 2019
- Kathleen Liddell, Mateo Aboy, Cristina Crespo, Glenn Cohen, John Liddicoat, Sara Gerke, Timo Minssen, ‘How does emerging patent case law in the US and Europe affect precision medicine?’, (2019) 57(10) Nature Biotechnology 1118-1126
- Kathleen Liddell, M Aboy, C Crespo, T Minssen, J Liddicoat, ‘Mayo's impact on patent applications related to biotech, diagnostics, and personalized medicine’, (2019) 37 Nature Biotechnology 513-518
- Kathleen Liddell, J Liddicoat, A McCarthy, S Hogarth, M Aboy, D Nicol, S Patton, M Hopkins, ‘Continental Drift? Do European Clinical Genetic Laboratories have a Patent Problem?’, (2019) 27 European Journal of Human Genetics European Journal of Human Genetics 997-1007
- Kathleen Liddell, M Aboy C Crespo, J Liddicoat, M Jordan, ‘Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?’, (2018) 36 Nature Biotechnology 1146
- Kathleen Liddell, Mateo Aboy, Johnathon Liddicoat, Matthew Jordan, Cristina Crespo, ‘After Myriad, what makes a gene patent claim 'markedly different' from nature?’, (2017) 35(9) Nature Biotechnology 820
- Kathleen Liddell, M Aboy, J Liddicoat, C Crespo, ‘Myriad's impact on gene patents’, (2016) 34(11) Nature Biotechnology 1119
- Kathleen Liddell, M Waibel, ‘Fair and Equitable Treatment and National Patent Law Flexibilities’, (2016) 19(1) Journal of International Economic Law 145-174
- Kathleen Liddell, M Dyson, C Watson, N Padfield, JA Bradley, K Saeb-Parsy, ‘Transplanting suboptimum organs: medico-legal implications’, (2015) 386 Lancet 719-721
- Kathleen Liddell, CU Köser, B Javid, MJ Ellington, S Feuerriegel, S Niemann, NM Brown, WJ Burman, I Abubakar, NA Ismail, D Moore, SJ Peacock, ME Török, ‘Drug-resistance mechanisms and tuberculosis drugs’, (2015) 385 (9965) Lancet 305-7
- Kathleen Liddell, E Jones, ‘Should healthy volunteers in clinical trials be paid according to risk? Yes.’, (2009) 339:b4142 British Medical Journal
- Kathleen Liddell, S Gaisser, M Hopkins, E Zika, D Ibarreta, ‘The phantom menace of gene patents’, (2009) 458 (7237) Nature 407-9
- Kathleen Liddell, S Hogarth, D Melzer, R Zimmern, ‘Patents as Incentives for Translational and Evaluative Research: the case of genetic tests and their improved clinical performance’, (2008) 3 Intellectual Property Quarterly 286-327
- Kathleen Liddell, D Melzer, S Hogarth, T Ling, S Sanderson, R L Zimmern, ‘Genetic tests for common diseases: new insights, old concerns’, (2008) 336 (7644) British Medical Journal 590-3
- Kathleen Liddell, S Hogarth, T Ling, S Sanderson, R Zimmern, D Melzer, ‘Closing the gaps - enhancing the regulation of genetic tests using responsive regulation’, (2007) 62(4) Food and Drug Law Journal 831-48
- Kathleen Liddell, J Bion, D Chamberlain, C Druml, E Kompanje, F Lemaire, D Menon, B Vhrovac, C Wiederman, ‘Medical Research Involving Incapacitated Adults: Implications of the EU Clinical Trials Directive 2001/20/EC’, (2006) 14 Medical Law Review 367-417
- Kathleen Liddell, D Chamberlain, et al, ‘The European Clinical Trials Directive Revisited: The VISEAR Recommendations’, (2006) 69(1) Resuscitation 9-14
- Kathleen Liddell, A Hall, ‘Beyond Bristol and Alder Hey: The Future Regulation of Human Tissue’, (2005) 13(2) Medical Law Review 170-223
- Kathleen Liddell, S Wallace, ‘Emerging Regulatory Issues for Human Stem Cell Medicine’, (2005) 1(1) Genomics Society and Policy 54
- Kathleen Liddell, ‘Biolaw and Deliberative Democracy: Regulating Human Genetic Technology in a Morally Pluralist Society’, D.Phil thesis, Faculty of Law, University of Oxford, 2003
- Kathleen Liddell, J liddicoat, J Skopek, ‘Precision Medicine: Legal and Ethical Challenges’, 2017
- Kathleen Liddell, J Liddicoat, ‘Open Innovation with Large Bioresources: Goals, Challenges and Proposals (Workshop Report)’, 2016
- Kathleen Liddell, ‘Realising Genomic Medicine: Intellectual Property Issues (Workshop Report)’, 2015
- Kathleen Liddell, ‘Human Bodies in Medicine and Research: Regulatory frameworks and their impact: a comparative report on the literature. A Report for the Nuffield Council on Bioethics for use in its report on Human Bodies in Medicine and Research (Working paper 2011)’, 2011
- Kathleen Liddell, S Hogarth, T Ling, D Melzer, S Sanderson, R Zimmern, ‘Regulating Pharmacogenomics: An overview of developments in various countries and industry response to regulatory initiatives: A report for Health Canada’, 2006
- Kathleen Liddell, ‘Legal and Governance Framework for 'Personal Data for Public Good: Using Health Information in Medical Research'’, 2006
- Kathleen Liddell, Oonah Corrigan, John McMillan, Alison Stewart, Susan Wallace, ‘Ethical, Legal and Social Issues in Stem Cell Research and Therapy’, 2005
- Kathleen Liddell, J Liddicoat, ‘Should we change EU law to disallow DNA patents?’, 2016